The number of stem cell transplants performed on in-patients in Finland has exhibited significant fluctuations over the past decade. Starting at 268 procedures in 2013, the annual values saw marked increases and decreases—peaking at 401 in 2017, dropping sharply to 207 in 2019, and recovering to 351 procedures by 2023. Year-on-year variations indicate substantial year-to-year volatility, with notable drops such as -39.3% in 2019 and considerable surges exemplified by a 62.8% increase in 2020.
Looking at compound annual growth rates (CAGR), which provide insight into longer-term trends, the past five years (2019-2023) show a modest average annual growth of 0.58%. The forecast for the upcoming period (2024-2028) suggests a positive trajectory, with a predicted 5-year CAGR of 2.31%, leading to a forecasted volume of 407 procedures by 2028.
Future trends to watch for:
- Advances in medical technology might drive increased efficiency and success rates for stem cell transplants.- Potential policy and healthcare funding changes could impact the number of procedures.- Demographic shifts, particularly the aging population, might lead to higher demand.- Continued research and clinical trials could introduce new stem cell therapy applications.
